Sort
21,453 grants matching “tuberculosis”
Sequence Determinants of Protein Structure and Stability
$430,141Robert T Sauer · Massachusetts Institute Of Technology · R01 · FY2017 · GM
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity
$430,078Jonathan E Golub · Johns Hopkins University · R01 · FY2025 · AI
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
$430,074Heinz Gernot Remold · Brigham And Women'S Hospital · R01 · FY2009 · AI
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
$430,007Turgay Ayer · Georgia Tech Research Corporation · · FY2017 · CSE
CAREER: Nonlinear Control for Single Molecule Tracking
$430,000Sean B Andersson · Trustees Of Boston University · · FY2009 · ENG
T cell responses to CD1-restricted lipids in tuberculosis
$429,969David Branch Moody · Brigham And Women'S Hospital · R01 · FY2011 · AI
Deoxyribozyme sensor-based diagnostics for Mycobacterium tuberculosis
$429,965Dmitry Mikhaylovich Kolpashchikov · University Of Central Florida · R15 · FY2013 · AI
Biosynthesis of nucleoside antibiotics targeting bacterial translocase
$429,934Steven Gary Van Lanen · University Of Kentucky · R01 · FY2012 · AI
Medicinal Chemistry Core
$429,875Joel Stephen Freundlich · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
ApoVax104-TB as a Novel Vaccine for Tuberculosis
$429,811Kathryn J. Macleod · Apovax, Inc. · R43 · FY2009 · AI
T cell Responses to CD1-restricted Lipids in Tuberculosis
$429,784David Branch Moody · Brigham And Women'S Hospital · R01 · FY2018 · AI
T cell Responses to CD1-restricted Lipids in Tuberculosis
$429,767David Branch Moody · Brigham And Women'S Hospital · R01 · FY2020 · AI
Modeling Core
$429,688Nitin S Baliga · Seattle Children'S Hospital · U19 · FY2019 · AI
NPHCO Core
$429,660Javier Crespo · Univ Of Massachusetts Med Sch Worcester · UG4 · FY2021 · LM
NPHCO Core
$429,660Javier Crespo · Univ Of Massachusetts Med Sch Worcester · UG4 · FY2025 · LM
NPHCO Core
$429,660Javier Crespo · Univ Of Massachusetts Med Sch Worcester · UG4 · FY2024 · LM
NPHCO Core
$429,660Javier Crespo · Univ Of Massachusetts Med Sch Worcester · UG4 · FY2023 · LM
Genetic Control of Pulmonary Cavities in Tuberculosis
$429,582University Of Texas Hlth Sci Ctr Houston · R01 · FY2004 · HL
Evaluating regimen efficacy using transcriptomic patterns of Mycobacterium tuberculosis injury and adaptation: high dimensional pharmacodynamics as a steppingstone to rational regimen design.
$429,546Camille M. Moore · National Jewish Health · R21 · FY2025 · AI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340
$429,509Carolyn Calfee · University Of California, San Francisco · P50 · FY2016 · CA
Bacterial and host determinants of progression, manifestations and consequences of TB
$429,311Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2022 · AI
Bayesian models to accelerate antibacterial drug discovery
$429,294Joel Stephen Freundlich · Rbhs-New Jersey Medical School · U19 · FY2017 · AI
STUDIES OF M TUBERCULOSIS SURVIVAL IN ANIMAL MODELS
$429,263Public Health Research Institute · R01 · FY2002 · HL
Project 3. Defining the RNA processing and degradation pathways of Mtb.
$429,263Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
STUDIES OF M TUBERCULOSIS SURVIVAL IN ANIMAL MODELS
$429,263Public Health Research Institute · R01 · FY2003 · HL